NYS HPV Coalition studying Counties with the lowest HPV vaccination Coverage: Medical Student receives prestigious award to support research
Throughout June and July 2023 a team of 7 people have been busy identifying, recruiting, and interviewing key informants in 15 New York counties to identify and better understand the barriers to receiving the HPV vaccine. The study team is being led by Dr. Jana Shaw (Principle Investigator), Samantha Hanley and, Michael Seserman and includes a group of resilient data collectors (Maribel Vargas, Karina Ohri, Elena Shaw, and Arielle Hanley). Samantha Hanley, a Medical Student at SUNY Upstate Medical University, was awarded the 2023 Alpha Omega Alpha (AΩA) Carolyn Kuckein Research Fellowship Award for the project. The results will help inform future interventions developed by the Coalition to address pockets of populations with low HPV vaccination uptake.
NYS HPV ECHO Series
In the Spring of 2022, the NYS HPV Coalition offered pediatric and family care providers an exciting opportunity to participate in an HPV ECHO Series. The one hour sessions took place on March 14, April 4, April 25, and May 16 and featured expert presenters, case studies, and group discussion. To view the sessions or download the slides and resources click here or go to www.echo.cancer.org
An HPV Vaccination Provider Report Card developed by the NYS HPV Coalition was sent to all vaccinating providers outside of NYC starting in October 2020. NYC already has a similar provider report card which includes HPV.
Listen to the recording of the June 17th, 2020 webinar entitled Increasing HPV vaccination and reducing missed opportunities in clinical settings.
New York State Health Organizations Urge Schools to Do More for HPV Cancer Prevention
Report Provides Evidence-Based Strategies to Increase HPV Vaccination Rates in School-Based Health Centers
Albany, NY (June 20, 2019) – The New York State HPV Coalition issued a report titled “NYS HPV Vaccination Guide For School-Based Health Centers” urging school-based health centers (SBHC) to implement HPV vaccination as part of standard care and providing recommendations on how to do so. The NYS HPV Coalition, which includes the American Cancer Society and American Academy of Pediatrics – Chapter 1 in partnership with the New York School-Based Health Alliance, will distribute the report to 255 SBHCs on June 20, 2019. The expected outcome of releasing the new guide is that at least 30 SBHCs in the state will implement the recommended strategies to increase HPV vaccination. A survey will be administered to assess changes to SBHCs over the next 18 months and to track any increases in their HPV vaccination rates as a result of using the guide.
“Strong provider
recommendation is the number one reason parents choose to vaccinate their
children against HPV, and many parents across
New York send their children to school-based health centers for acute and
preventive care,” says Dr. Jana Shaw, Chief Medical Officer of North
Country Family Health Center and Chair of the
Public Education Committee of the NYS HPV Coalition.
“So, it’s critical that this vaccine is being effectively implemented in these healthcare
settings in order to protect our children from cancer in the future.”
It is estimated
that nearly 375,000 adolescents in New York have not been vaccinated against
HPV placing them at increased future risk for six different types of HPV-related
cancer. SBHCs serve 180,520
students statewide.
The
report details the importance of HPV vaccination for cancer prevention and the
current burden of HPV and HPV-related cancers. There
are 79 million new cases of HPV annually in the United States, and HPV is responsible or a combined
30,700 cases of cervical, vaginal, vulvar, penile, anal, and oropharyngeal
cancers in the United States each year. HPV causes virtually all cervical
cancers, 90 percent of anal cancers, about 70 percent of oropharyngeal cancers,
and 60-70 percent of vaginal, vulvar, and penile cancers.
“The HPV vaccine was approved
by the FDA in 2006, but today less than 54 percent of eligible adolescents are
being vaccinated in New York,” says Michael Seserman, Manager of State Health
and Primary Care Systems for the American Cancer Society and Co-Chair of the
NYS HPV Coalition. “The goal of the NYS HPV Coalition is to increase HPV
vaccination completion rates to 80 percent among 13 to 17-year-old adolescents
in New York by 2023. It’s an ambitious goal, but we need to do more to protect
our children from cancer.”
If
effectively implemented, parents of students who receive care at school-based
health centers can expect:
Calls and postcards from SBHC’s reminding parents about HPV vaccination when their child is recommended to receive the vaccine (age 11-12).
Electronic reminders, including text messages and emails, about missed vaccinations.
Educational materials about HPV vaccination and cancer prevention.
And, in some cases, integration of Beneath the surFACE into secondary school curricula – an educational program focused on head and neck cancer causes, prevention, and minimizing risk factors through smart lifestyle choices.
“Our hope is that, come fall 2019, healthcare
professionals in every school-based health center in New York will not only be
recommending the HPV vaccine for students ages 11 to 12, but doing so using
effective, evidence-based strategies,” says Sarah Murphy, Executive Director of
the School-Based Health Alliance.
HPV vaccination is recommended for both girls
and boys between the ages 11 to 12. If children are vaccinated within this
target age range, two shots are needed six months apart. Three shots are needed
for people 15 years and older. For more information about HPV vaccination,
visit https://www.cancer.org/healthy/hpv-vaccine.html.
News and Events
NYS HPV Coalition studying Counties with the lowest HPV vaccination Coverage: Medical Student receives prestigious award to support research
Throughout June and July 2023 a team of 7 people have been busy identifying, recruiting, and interviewing key informants in 15 New York counties to identify and better understand the barriers to receiving the HPV vaccine. The study team is being led by Dr. Jana Shaw (Principle Investigator), Samantha Hanley and, Michael Seserman and includes a group of resilient data collectors (Maribel Vargas, Karina Ohri, Elena Shaw, and Arielle Hanley). Samantha Hanley, a Medical Student at SUNY Upstate Medical University, was awarded the 2023 Alpha Omega Alpha (AΩA) Carolyn Kuckein Research Fellowship Award for the project. The results will help inform future interventions developed by the Coalition to address pockets of populations with low HPV vaccination uptake.
NYS HPV ECHO Series
NYS HPV Coalition announces the first annual NYS HPV Vaccination Honor Roll Awards
An HPV Vaccination Provider Report Card developed by the NYS HPV Coalition was sent to all vaccinating providers outside of NYC starting in October 2020. NYC already has a similar provider report card which includes HPV.
Continuing education webinar for dental professionals entitled “HPV Vaccine to Prevent Oropharyngeal Cancer: Improving Quality and Saving Lives.”
Listen to the recording of the June 17th, 2020 webinar entitled Increasing HPV vaccination and reducing missed opportunities in clinical settings.
New York State Health Organizations Urge Schools to Do More for HPV Cancer Prevention
Report Provides Evidence-Based Strategies to Increase HPV Vaccination Rates in School-Based Health Centers
Albany, NY (June 20, 2019) – The New York State HPV Coalition issued a report titled “NYS HPV Vaccination Guide For School-Based Health Centers” urging school-based health centers (SBHC) to implement HPV vaccination as part of standard care and providing recommendations on how to do so. The NYS HPV Coalition, which includes the American Cancer Society and American Academy of Pediatrics – Chapter 1 in partnership with the New York School-Based Health Alliance, will distribute the report to 255 SBHCs on June 20, 2019. The expected outcome of releasing the new guide is that at least 30 SBHCs in the state will implement the recommended strategies to increase HPV vaccination. A survey will be administered to assess changes to SBHCs over the next 18 months and to track any increases in their HPV vaccination rates as a result of using the guide.
“Strong provider recommendation is the number one reason parents choose to vaccinate their children against HPV, and many parents across New York send their children to school-based health centers for acute and preventive care,” says Dr. Jana Shaw, Chief Medical Officer of North Country Family Health Center and Chair of the Public Education Committee of the NYS HPV Coalition. “So, it’s critical that this vaccine is being effectively implemented in these healthcare settings in order to protect our children from cancer in the future.”
It is estimated that nearly 375,000 adolescents in New York have not been vaccinated against HPV placing them at increased future risk for six different types of HPV-related cancer. SBHCs serve 180,520 students statewide.
The report details the importance of HPV vaccination for cancer prevention and the current burden of HPV and HPV-related cancers. There are 79 million new cases of HPV annually in the United States, and HPV is responsible or a combined 30,700 cases of cervical, vaginal, vulvar, penile, anal, and oropharyngeal cancers in the United States each year. HPV causes virtually all cervical cancers, 90 percent of anal cancers, about 70 percent of oropharyngeal cancers, and 60-70 percent of vaginal, vulvar, and penile cancers.
“The HPV vaccine was approved by the FDA in 2006, but today less than 54 percent of eligible adolescents are being vaccinated in New York,” says Michael Seserman, Manager of State Health and Primary Care Systems for the American Cancer Society and Co-Chair of the NYS HPV Coalition. “The goal of the NYS HPV Coalition is to increase HPV vaccination completion rates to 80 percent among 13 to 17-year-old adolescents in New York by 2023. It’s an ambitious goal, but we need to do more to protect our children from cancer.”
If effectively implemented, parents of students who receive care at school-based health centers can expect:
“Our hope is that, come fall 2019, healthcare professionals in every school-based health center in New York will not only be recommending the HPV vaccine for students ages 11 to 12, but doing so using effective, evidence-based strategies,” says Sarah Murphy, Executive Director of the School-Based Health Alliance.
HPV vaccination is recommended for both girls and boys between the ages 11 to 12. If children are vaccinated within this target age range, two shots are needed six months apart. Three shots are needed for people 15 years and older. For more information about HPV vaccination, visit https://www.cancer.org/healthy/hpv-vaccine.html.